<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02362022</url>
  </required_header>
  <id_info>
    <org_study_id>14.09.2007/88-4</org_study_id>
    <nct_id>NCT02362022</nct_id>
  </id_info>
  <brief_title>The Effects of Morphine on Desflurane Consumption and Recovery Time</brief_title>
  <official_title>Comparison of Two Different Doses of Intravenous Morphine on Desflurane Consumption and Recovery Time in Patients Undergoing Total Abdominal Hysterectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Baskent University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Baskent University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Combination of volatile and opioid agents are used to achieve unconsciousness, haemodynamic
      stability and analgesia for surgical prosedures. This prospective, randomized, double-blind,
      controlled study evaluates the effects of two different doses of morphine sulphate (0.1 mg/kg
      and 0.2 mg/kg), on desflurane consumption, recovery characteristics, postoperative analgesic
      requirements and side effects during total abdominal hysterectomy.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2007</start_date>
  <completion_date type="Actual">December 2007</completion_date>
  <primary_completion_date type="Actual">December 2007</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>postoperative desflurane consumption</measure>
    <time_frame>postoperative first hour</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>sedation scores for OASS scale</measure>
    <time_frame>postoperative first hour</time_frame>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">90</enrollment>
  <condition>Abdominal Hysterectomy (&amp; Wertheim)</condition>
  <arm_group>
    <arm_group_label>Group Saline</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Group Saline (Group S) received i.v saline 0.9 % in 10 ml volume (n=30)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group Morphine 1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Group Morphine 1 (Group M1) received i.v morphine 0.1 mg kg-1, in 10 ml volume (n=30)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group Morphine 2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Group Morphine 2 (Group M2) received i.v morphine 0.2 mg kg-1, in 10 ml volume (n=30)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Morphine</intervention_name>
    <description>Group Saline (Group S): Received i.v saline 0.9 % in 10 ml volume (n=30) Group Morphine 1 (Group M1): Received i.v morphine 0.1 mg kg-1 in 10 ml volume (n=30) Group Morphine 2 (Group M2): Received i.v morphine 0.2 mg kg-1 in 10 ml volume (n=30)</description>
    <arm_group_label>Group Saline</arm_group_label>
    <arm_group_label>Group Morphine 1</arm_group_label>
    <arm_group_label>Group Morphine 2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  undergoing total abdominal hysterectomy with general anaesthesia

        Exclusion Criteria:

          -  renal dysfunction (cre&gt;1.2), liver failure, cardiovascular, psychiatric, allergic and
             metabolic disorders
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>cagla bali</last_name>
    <role>Principal Investigator</role>
    <affiliation>Baskent University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Baskent University School of Medicine Adana Teaching and Research Hospital</name>
      <address>
        <city>Adana</city>
        <zip>01250</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>June 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 4, 2015</study_first_submitted>
  <study_first_submitted_qc>February 7, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 12, 2015</study_first_posted>
  <last_update_submitted>December 2, 2015</last_update_submitted>
  <last_update_submitted_qc>December 2, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 3, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Baskent University</investigator_affiliation>
    <investigator_full_name>CAGLA BALI,MD</investigator_full_name>
    <investigator_title>medical doctor</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Morphine</mesh_term>
    <mesh_term>Desflurane</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

